Bacteriophage Therapy of Chronic Nonhealing Wound: Clinical Study

A chronic wound usually results due to halt in the inflammatory phase of wound healing. Bacterial infections and biofilm formation are considered to be the basic cause of it. Chronic wounds significantly impair the quality of life. Antibiotics are now failing due to biofilm formation emergence of dr...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of lower extremity wounds Vol. 18; no. 2; p. 171
Main Authors Gupta, Pooja, Singh, Hari Shankar, Shukla, Vijay K, Nath, Gopal, Bhartiya, Satyanam Kumar
Format Journal Article
LanguageEnglish
Published United States 01.06.2019
Subjects
Online AccessGet more information
ISSN1552-6941
DOI10.1177/1534734619835115

Cover

Loading…
Abstract A chronic wound usually results due to halt in the inflammatory phase of wound healing. Bacterial infections and biofilm formation are considered to be the basic cause of it. Chronic wounds significantly impair the quality of life. Antibiotics are now failing due to biofilm formation emergence of drug-resistant bacteria. This study aims to see the effect of bacteriophage therapy in chronic nonhealing wound infected with the following bacteria: . Patients with chronic nonhealing wound not responding to conventional local debridement and antibiotic therapy were included in the study. The age of patients ranged between 12 and 60 years. A total of 20 patients selected and tissue biopsies and wound swabs were taken for isolation of the bacteria. After confirmation of organism, a cocktail of customized bacteriophages was topically applied over the wound on alternate days till the wound surface became microbiologically sterile. Mean bacterial count and clinical assessment were done and compared at the time of presentation and after 3 and 5 doses of application. A significant improvement was observed in the wound healing, and there were no signs of infection clinically and microbiologically after 3 to 5 doses of topical bacteriophage therapy. Seven patients achieved complete healing on day21 during follow up while in others healthy margins and healthy granulation tissue were observed. Topical bacteriophage application may be quite effective therapy for the treatment of chronic nonhealing wounds.
AbstractList A chronic wound usually results due to halt in the inflammatory phase of wound healing. Bacterial infections and biofilm formation are considered to be the basic cause of it. Chronic wounds significantly impair the quality of life. Antibiotics are now failing due to biofilm formation emergence of drug-resistant bacteria. This study aims to see the effect of bacteriophage therapy in chronic nonhealing wound infected with the following bacteria: . Patients with chronic nonhealing wound not responding to conventional local debridement and antibiotic therapy were included in the study. The age of patients ranged between 12 and 60 years. A total of 20 patients selected and tissue biopsies and wound swabs were taken for isolation of the bacteria. After confirmation of organism, a cocktail of customized bacteriophages was topically applied over the wound on alternate days till the wound surface became microbiologically sterile. Mean bacterial count and clinical assessment were done and compared at the time of presentation and after 3 and 5 doses of application. A significant improvement was observed in the wound healing, and there were no signs of infection clinically and microbiologically after 3 to 5 doses of topical bacteriophage therapy. Seven patients achieved complete healing on day21 during follow up while in others healthy margins and healthy granulation tissue were observed. Topical bacteriophage application may be quite effective therapy for the treatment of chronic nonhealing wounds.
Author Nath, Gopal
Shukla, Vijay K
Singh, Hari Shankar
Bhartiya, Satyanam Kumar
Gupta, Pooja
Author_xml – sequence: 1
  givenname: Pooja
  surname: Gupta
  fullname: Gupta, Pooja
  organization: 1 Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
– sequence: 2
  givenname: Hari Shankar
  surname: Singh
  fullname: Singh, Hari Shankar
  organization: 2 Department of General Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
– sequence: 3
  givenname: Vijay K
  surname: Shukla
  fullname: Shukla, Vijay K
  organization: 2 Department of General Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
– sequence: 4
  givenname: Gopal
  surname: Nath
  fullname: Nath, Gopal
  organization: 1 Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
– sequence: 5
  givenname: Satyanam Kumar
  surname: Bhartiya
  fullname: Bhartiya, Satyanam Kumar
  organization: 2 Department of General Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31081402$$D View this record in MEDLINE/PubMed
BookMark eNo1jztPwzAURi0Eog_YmZD_QMDXju2ErUTlIVUwUMRYOfZ1E5TaUR5D_j2RgOnTWT6dsyLnIQYk5AbYHYDW9yBFqkWqIM-EBJBnZAlS8kTlKSzIqu-_GePAcn1JFgJYBinjS7J5NHbAro5tZY5I9xV2pp1o9LSouhhqS99iqNA0dTjSrzgG90CLGWprGvoxjG66IhfeND1e_-2afD5t98VLsnt_fi02u8QKoYfE6JILjc4AeMeVA5OVqiwFm5299l7LWc3mqEBYdLnKM2fQopwx1cx7via3v7_tWJ7QHdquPpluOvy38B9WeEt4
CitedBy_id crossref_primary_10_1111_jam_15647
crossref_primary_10_3390_ijms25105465
crossref_primary_10_3390_antibiotics9110754
crossref_primary_10_3389_fphar_2021_615445
crossref_primary_10_3390_molecules28166098
crossref_primary_10_1155_2024_6252415
crossref_primary_10_3390_antibiotics12020286
crossref_primary_10_3390_ph13100299
crossref_primary_10_1128_MMBR_00012_19
crossref_primary_10_3390_antibiotics9070377
crossref_primary_10_1016_j_ijpharm_2024_124348
crossref_primary_10_3390_ph14111157
crossref_primary_10_3390_ijms23094577
crossref_primary_10_1177_1534734619863116
crossref_primary_10_3389_fbioe_2024_1319830
crossref_primary_10_1371_journal_pone_0243947
crossref_primary_10_1016_j_tim_2021_04_008
crossref_primary_10_3390_antibiotics13020125
crossref_primary_10_3390_biomedicines11102860
crossref_primary_10_1099_jmm_0_001895
crossref_primary_10_1097_TP_0000000000003565
crossref_primary_10_1177_19386400231225708
crossref_primary_10_1016_j_cmi_2023_01_011
crossref_primary_10_3390_ph14010034
crossref_primary_10_1016_j_jgar_2024_07_019
crossref_primary_10_3390_toxins13070491
crossref_primary_10_1002_adma_202201210
crossref_primary_10_1177_15347346211072779
crossref_primary_10_3390_ph16121638
crossref_primary_10_1007_s40121_022_00591_2
crossref_primary_10_3390_antibiotics12040751
crossref_primary_10_3390_pharmaceutics16030374
crossref_primary_10_1007_s15010_024_02178_0
crossref_primary_10_3390_biology13020109
crossref_primary_10_1016_j_indcrop_2025_120608
crossref_primary_10_1080_23744235_2024_2379492
crossref_primary_10_1186_s40634_023_00586_z
crossref_primary_10_1016_j_virol_2023_06_009
crossref_primary_10_1111_jam_15642
crossref_primary_10_3390_antibiotics10121497
crossref_primary_10_3389_fmed_2023_1209782
crossref_primary_10_3390_ph14040331
crossref_primary_10_1007_s00253_021_11695_z
crossref_primary_10_32604_biocell_2023_029564
crossref_primary_10_1177_15347346231226342
crossref_primary_10_1002_phar_2806
crossref_primary_10_1161_JAHA_121_023080
crossref_primary_10_1055_s_0040_1715773
crossref_primary_10_3390_v16030478
crossref_primary_10_5005_jp_journals_10068_3053
crossref_primary_10_1016_S1473_3099_21_00612_5
crossref_primary_10_22141_2224_0586_20_5_2024_1740
crossref_primary_10_1007_s11908_020_00742_x
crossref_primary_10_1186_s40001_023_01121_7
crossref_primary_10_7759_cureus_71542
crossref_primary_10_3390_microbiolres13010002
crossref_primary_10_3390_v16081275
crossref_primary_10_3390_ph18010081
crossref_primary_10_1080_14787210_2021_1858800
crossref_primary_10_3390_antibiotics12081329
crossref_primary_10_1093_burnst_tkae083
crossref_primary_10_1007_s12223_021_00946_1
crossref_primary_10_36610_j_jsaas_2022_090200097x
crossref_primary_10_1038_s41598_021_98457_z
crossref_primary_10_2174_0118742858281566231221045303
crossref_primary_10_3390_antibiotics8040182
crossref_primary_10_1111_wrr_13240
crossref_primary_10_1111_1751_7915_13465
crossref_primary_10_3390_ijms25010201
crossref_primary_10_1016_j_jconrel_2023_10_029
crossref_primary_10_3390_antibiotics10050556
crossref_primary_10_3390_v15071427
crossref_primary_10_1038_s41598_025_92032_6
crossref_primary_10_1128_spectrum_03702_22
crossref_primary_10_36290_der_2023_028
crossref_primary_10_1016_j_actpha_2022_07_042
crossref_primary_10_3390_v12020235
crossref_primary_10_3390_v13061175
crossref_primary_10_1016_j_mtbio_2023_100612
crossref_primary_10_1080_08927014_2021_1955866
crossref_primary_10_1007_s00203_024_04168_0
crossref_primary_10_1186_s12893_022_01521_2
crossref_primary_10_3390_v14122760
crossref_primary_10_1016_j_apsb_2022_05_007
crossref_primary_10_3390_v16071051
crossref_primary_10_36610_j_jsaas_2022_090200097
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1177/1534734619835115
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
EISSN 1552-6941
ExternalDocumentID 31081402
Genre Journal Article
Observational Study
GroupedDBID ---
-TM
.2E
.2J
.2N
01A
0R~
123
1~K
29J
31R
31U
31X
31Z
4.4
53G
54M
5VS
AABMB
AACMV
AACTG
AADTT
AADUE
AAEWN
AAGMC
AAJPV
AAKGS
AAQDB
AAQXI
AARDL
AARIX
AATAA
AATBZ
AAUAS
AAWTL
ABAWP
ABCCA
ABCJG
ABEIX
ABFWQ
ABHQH
ABJNI
ABKRH
ABLUO
ABPNF
ABQXT
ABRHV
ABUJY
ABVFX
ABXGC
ACARO
ACDSZ
ACDXX
ACFEJ
ACGFS
ACGZU
ACJER
ACJTF
ACLFY
ACLZU
ACOFE
ACOXC
ACROE
ACRPL
ACSBE
ACSIQ
ACTQU
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADNMO
ADNON
ADRRZ
ADVBO
ADYCS
ADZZY
AECGH
AEDTQ
AEFTW
AEKYL
AENEX
AEPTA
AEQLS
AERKM
AESZF
AEUHG
AEUIJ
AEWDL
AEWHI
AEXNY
AFEET
AFKRG
AFMOU
AFQAA
AFUIA
AFWMB
AGHKR
AGKLV
AGNHF
AGPXR
AGWFA
AGWNL
AHDMH
AHHFK
AIIQI
AIOMO
AJUZI
AJXAJ
ALKWR
ALMA_UNASSIGNED_HOLDINGS
ALTZF
AMCVQ
ANDLU
ARTOV
ASPBG
AUTPY
AUVAJ
AVWKF
AYAKG
AZFZN
B3H
B8M
B8R
B8Z
B94
BBRGL
BDDNI
BKIIM
BKSCU
BPACV
BSEHC
BWJAD
C45
CAG
CDWPY
CFDXU
CGR
COF
CS3
CUY
CVF
DB0
DC-
DC.
DF0
DO-
DOPDO
DV7
DV9
EBS
ECM
EIF
EJD
EMOBN
F5P
FEDTE
FHBDP
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HF~
HVGLF
HZ~
IAO
IEA
IHR
INH
INR
IVC
J8X
K.F
M4V
N9A
NPM
O9-
OVD
P.B
P2P
Q7L
Q7U
Q83
RIG
ROL
S01
SAUOL
SCNPE
SDB
SFC
SFK
SFT
SGO
SGR
SGV
SGZ
SHG
SNB
SPJ
SPP
SPQ
SPV
STM
TEORI
ZONMY
ZPPRI
ZRKOI
ZSSAH
ID FETCH-LOGICAL-c337t-a7b237eda11fd26d1a8b6bb30734f7ff75097c9e613ced9698daece513c470ff2
IngestDate Wed Feb 19 02:26:42 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords microbial infection
antibiotic resistance
topical bacteriophage therapy
chronic wound
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c337t-a7b237eda11fd26d1a8b6bb30734f7ff75097c9e613ced9698daece513c470ff2
PMID 31081402
ParticipantIDs pubmed_primary_31081402
PublicationCentury 2000
PublicationDate 2019-Jun
PublicationDateYYYYMMDD 2019-06-01
PublicationDate_xml – month: 06
  year: 2019
  text: 2019-Jun
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle International journal of lower extremity wounds
PublicationTitleAlternate Int J Low Extrem Wounds
PublicationYear 2019
SSID ssj0021097
Score 2.4528167
Snippet A chronic wound usually results due to halt in the inflammatory phase of wound healing. Bacterial infections and biofilm formation are considered to be the...
SourceID pubmed
SourceType Index Database
StartPage 171
SubjectTerms Administration, Topical
Adolescent
Adult
Bacteriophages
Child
Chronic Disease
Escherichia coli - virology
Female
Humans
Male
Middle Aged
Normal Distribution
Phage Therapy - methods
Prognosis
Prospective Studies
Pseudomonas aeruginosa - virology
Staphylococcus aureus - virology
Statistics, Nonparametric
Wound Healing - physiology
Wound Infection - microbiology
Wound Infection - therapy
Young Adult
Title Bacteriophage Therapy of Chronic Nonhealing Wound: Clinical Study
URI https://www.ncbi.nlm.nih.gov/pubmed/31081402
Volume 18
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dj9JAEN-AJpd7MRrPOz01--DbpUjbbZf6hkQhJhIT4OSN7Gc4PlpiIBd98k93ptsPRC56vjSlSwvdmZ38ZnbmN4S8kcgZZZXvaeMnHjOJ9qQWzAtjI1WgZCwl1jt_HsaDCfs0jaaNxs-9rKXdVrbUj6N1Jf8jVbgGcsUq2XtItnooXIBzkC8cQcJw_CcZv3dUy9lmjpk3Y0cQ4BIsXGebYZYiEsRwwFfsn4T-f6-shRxVzLKLOp29jg7ucUqssJXaFZjxb2aNqP0Wn1WB8f5u4yDolyxbVFZ-BD-ah2wG4I0jL3S6FFUi8Gi-W67ye65vFuJ7HWsdChfn6YMvv9qPSGARVJk51TKFFY0CDytkj5vZytt1NtN3PVj-tOX5bjJYZMZDBn5eB_c8o_2vwqRt1rlsAaQidVfw99EDdu1yqEma4Gdg41SM9hQOO-7O11vbbw__yik5KW8_cEpycDJ-TB4VXgXtOhV5QhomfUq6v6kHLdSDZpYW6kFr9aC5eryjpXLQXDnOyOTjh3Fv4BUdMzwVhnzrCS6DkBstfN_qINa-6OBqQzvOLLcW4SFXiQEMp4xO4qSjhVEmgo-Mt60NnpEHaZaaC0JFKDRAQSsVZyxisH7bynCMpkgu26F5Ts7dG882jhZlVs7FiztHLslprS8vyUML69C8AlC3la_zmf8FFnRNIw
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bacteriophage+Therapy+of+Chronic+Nonhealing+Wound%3A+Clinical+Study&rft.jtitle=International+journal+of+lower+extremity+wounds&rft.au=Gupta%2C+Pooja&rft.au=Singh%2C+Hari+Shankar&rft.au=Shukla%2C+Vijay+K&rft.au=Nath%2C+Gopal&rft.date=2019-06-01&rft.eissn=1552-6941&rft.volume=18&rft.issue=2&rft.spage=171&rft_id=info:doi/10.1177%2F1534734619835115&rft_id=info%3Apmid%2F31081402&rft_id=info%3Apmid%2F31081402&rft.externalDocID=31081402